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Is There a Stigma Associated With Pilots Taking Medication? 
 
According to FAA regulations, commercial pilots are allowed to take certain approved medications. 
Previous research has shown that people who take certain medication can be exposed to social stigmas 
if others know about their medication intake. This is particularly true for medications prescribed for 
mental illness. No research that we know has analyzed how aviation consumers would react to the 
knowledge that the pilot of their commercial aircraft is taking medication, or how the type of 
medication and dosage might differentially affect consumers’ willingness to fly. We presented 
participants with various scenarios about a pilot who has been taking one of four types  of medications 
(Prozac, Claritin, Ibuprofen or Catapres), or no medication at all at a low or high dosage. We then asked 
participants how they felt about the situation as well as their willingness to fly. We hypothesized that 
participants would feel more negatively about, and be less willing to fly in, situations where the pilot 
was taking medication, particularly at a high dosage. We also predicted that participants’ emotions 
would mediate the relationship between the type of medication and how willing participants were to fly 
in each scenario. Not surprisingly, the results revealed that participants were more negative about the 
pilot taking medications compared to the non-medication condition, and that a high dosage of 
medication was viewed more unfavorably than a low dosage. Interestingly, participants were especially 
negative about the pilot taking Prozac. Even the low dosage of Prozac generated stronger negative 
emotions, and less willingness to fly, than the high dosage of the other medications. Mediation analyses 
revealed that the relationship between type of medication and willingness to fly was fully mediated by 
participants’ emotions; that is, participants were basing their willingness to fly judgments solely on 
emotional, rather than cognitive, factors. This data supports previous findings in the mental health 
literature that taking anti-depressants can lead to social stigma that has wide-ranging effects on trust 
and other dependent variables. 
